Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs URA✓SelectedUSD · URAGSK vs URA performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs URA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+44.4%
URA return
+25.6%
Excess return
+18.7%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioURAExcessAlpha
1D+0.5%-1.6%+2.1%+0.6%
7D+1.1%-1.5%+2.7%+1.2%
30D+6.3%-10.4%+16.7%+6.8%
3M+1.8%-29.6%+31.4%+3.5%
6M+1.7%-40.3%+41.9%+4.2%
YTD+6.5%-25.5%+32.0%+7.0%
1Y+9.5%-26.4%+35.9%+9.9%
3Y+65.3%+31.4%+33.9%+53.7%
All+44.4%+25.6%+18.7%+33.0%

Cumulative growth

Daily Returns

Daily percentage return beside URA.

Daily Out/Under-Performance

Portfolio return minus URA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × URA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded URA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling